ZA200108130B - Treatment of pulmonary hypertension. - Google Patents

Treatment of pulmonary hypertension.

Info

Publication number
ZA200108130B
ZA200108130B ZA200108130A ZA200108130A ZA200108130B ZA 200108130 B ZA200108130 B ZA 200108130B ZA 200108130 A ZA200108130 A ZA 200108130A ZA 200108130 A ZA200108130 A ZA 200108130A ZA 200108130 B ZA200108130 B ZA 200108130B
Authority
ZA
South Africa
Prior art keywords
pulmonary hypertension
treatment
preparation
pharmaceutical composition
treating pulmonary
Prior art date
Application number
ZA200108130A
Other languages
English (en)
Inventor
Maha Ghazzi
Milton Lethan Pressler
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of ZA200108130B publication Critical patent/ZA200108130B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200108130A 2000-10-04 2001-10-03 Treatment of pulmonary hypertension. ZA200108130B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23753800P 2000-10-04 2000-10-04

Publications (1)

Publication Number Publication Date
ZA200108130B true ZA200108130B (en) 2002-06-06

Family

ID=22894157

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200108130A ZA200108130B (en) 2000-10-04 2001-10-03 Treatment of pulmonary hypertension.

Country Status (13)

Country Link
US (1) US6740648B2 (ko)
EP (1) EP1195166B1 (ko)
JP (1) JP3838065B2 (ko)
KR (1) KR100445946B1 (ko)
AT (1) ATE367815T1 (ko)
CA (1) CA2357833C (ko)
DE (1) DE60129518T2 (ko)
ES (1) ES2288899T3 (ko)
HU (1) HUP0104085A3 (ko)
IL (1) IL145684A (ko)
MY (1) MY136383A (ko)
NZ (1) NZ514542A (ko)
ZA (1) ZA200108130B (ko)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI322689B (en) 2003-02-24 2010-04-01 Otsuka Pharma Co Ltd Method for treating severe heart failure and medicament therefor
US20050159985A1 (en) * 2003-11-21 2005-07-21 Bertram Carl T. System and method of stratifying intervention groups and comparison groups based on disease severity index scores and ranges
US8532938B2 (en) 2005-11-17 2013-09-10 The Invention Science Fund I, Llc Testing-dependent administration of a nutraceutical
US8468029B2 (en) 2005-11-17 2013-06-18 The Invention Science Fund I, Llc Subscriptions for assistance related to health
US10042980B2 (en) * 2005-11-17 2018-08-07 Gearbox Llc Providing assistance related to health
US20070112592A1 (en) 2005-11-17 2007-05-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Payments in providing assistance related to health
US8340944B2 (en) 2005-11-30 2012-12-25 The Invention Science Fund I, Llc Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US20080103746A1 (en) 2005-11-30 2008-05-01 Searete Llc, A Limited Liability Corporation Systems and methods for pathogen detection and response
US7974856B2 (en) 2005-11-30 2011-07-05 The Invention Science Fund I, Llc Computational systems and methods related to nutraceuticals
US8297028B2 (en) 2006-06-14 2012-10-30 The Invention Science Fund I, Llc Individualized pharmaceutical selection and packaging
US10296720B2 (en) 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US8000981B2 (en) * 2005-11-30 2011-08-16 The Invention Science Fund I, Llc Methods and systems related to receiving nutraceutical associated information
US20090197922A1 (en) * 2006-01-24 2009-08-06 The University Of Chicago Compositions and methods for treating pulmonary hypertension
US7858666B2 (en) 2007-06-08 2010-12-28 Mannkind Corporation IRE-1α inhibitors
AU2009257174A1 (en) * 2008-06-09 2009-12-17 Dimerix Bioscience Pty Ltd Novel receptor hetero-dimers/-oligomers
CN103260670A (zh) 2010-10-15 2013-08-21 塞托弗尔克斯股份有限公司 细胞分离灌流器及其用途
JP2015503418A (ja) 2012-01-09 2015-02-02 エイチ. デビッド ヒュームズ 心筋機能を向上させるためのカートリッジおよび方法
US20150238502A1 (en) 2012-10-18 2015-08-27 University Of South Florida Compositions and Methods for Treating Stroke
US10509044B2 (en) * 2014-05-08 2019-12-17 University Of Maryland, Baltimore Methods for assessing differential risk for developing heart failure
US10518112B2 (en) * 2014-06-18 2019-12-31 Sonivie Ltd. Method for treating secondary pulmonary hypertension
CN110237077A (zh) * 2019-05-10 2019-09-17 辽宁大学 考尼伐坦在制备降血脂药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225402A (en) 1989-02-10 1993-07-06 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
US5258510A (en) * 1989-10-20 1993-11-02 Otsuka Pharma Co Ltd Benzoheterocyclic compounds
US5338755A (en) 1990-07-31 1994-08-16 Elf Sanofi N-sulfonylindoline derivatives, their preparation and the pharmaceutical compositions in which they are present
GB9307527D0 (en) * 1993-04-13 1993-06-02 Fujisawa Pharmaceutical Co New venzamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
NZ268671A (en) * 1993-07-21 1997-09-22 Yamanouchi Pharma Co Ltd Fused benzazepin-1-yl-carbonylphenyl derivatives
EP0716083A4 (en) 1993-08-26 1996-08-28 Yamanouchi Pharma Co Ltd BENZAZEPINE DERIVATIVES, PHARMACEUTICAL COMPOSITION CONTAINING THEM, AND INTERMEDIATES THEREOF
US5719155A (en) 1993-11-10 1998-02-17 Japan Tobacco Inc. Chroman derivative and pharmaceutical use thereof
FR2757157B1 (fr) * 1996-12-13 1999-12-31 Sanofi Sa Derives d'indolin-2-one, procede pour leur preparation et compositions pharmaceutiques les contenant
CA2319649A1 (en) * 1998-01-28 1999-08-05 Mitsunori Waki Preventives or remedies for vision disorders
IL144270A0 (en) * 1999-01-19 2002-05-23 Ortho Mcneil Pharm Inc Tricyclic benzodiazepines as vasopressin receptor antagonists
DE19906310A1 (de) * 1999-02-16 2000-08-17 Solvay Pharm Gmbh Arzneimittel zur Behandlung von Bluthochdruck

Also Published As

Publication number Publication date
HUP0104085A3 (en) 2004-11-29
MY136383A (en) 2008-09-30
HU0104085D0 (en) 2001-12-28
EP1195166B1 (en) 2007-07-25
IL145684A (en) 2007-06-17
EP1195166A2 (en) 2002-04-10
KR100445946B1 (ko) 2004-08-25
US6740648B2 (en) 2004-05-25
JP2002128696A (ja) 2002-05-09
HUP0104085A2 (hu) 2002-07-29
DE60129518T2 (de) 2008-03-20
EP1195166A3 (en) 2003-12-03
IL145684A0 (en) 2002-06-30
US20020128259A1 (en) 2002-09-12
KR20020027237A (ko) 2002-04-13
ES2288899T3 (es) 2008-02-01
ATE367815T1 (de) 2007-08-15
DE60129518D1 (de) 2007-09-06
CA2357833A1 (en) 2002-04-04
NZ514542A (en) 2002-10-25
CA2357833C (en) 2005-11-15
JP3838065B2 (ja) 2006-10-25

Similar Documents

Publication Publication Date Title
IL145684A0 (en) Treatment of pulmonary hypertension
DE60018100D1 (en) Polymorphe form von atorvastatin-calcium
AP1718A (en) 3-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors
GB0111523D0 (en) Chemical compounds
AU6048201A (en) Quinazoline derivatives for the treatment of tumours
HUP0004211A3 (en) Use of pde-5 inhibitors for the preparation of pharmaceutical compositions treating pulmonary hypertension
HK1083505A1 (en) Ccr5 antagonists useful for treating aids
IL192991A0 (en) Use of tetrahydrocarbazole derivatives for the manufacture of medicanents for treating gonadotropin-releasing hormone
IL143868A (en) Use of 3 - (2,4,6 - trimethylphenyl)- 4 - neopentylcarbonyloxy- 5, 5 - tetramethylene -delta 3 - dihydrofuran -2 -one for controlling the white fly
HK1042247A1 (en) Use of benzazepine-n ethanoic acid derivatives forpreparation of medicament for treating pulmonary hypertension.
MXPA03002909A (es) Compuestos quimicos.
PL350568A1 (en) N-(2-phenyl-4-aminobutyl)-1-naphtamides as antagonists of neurokinin 1 receptors
AU7287201A (en) Novel form of (R)-N-(5-methyl-8-(4-methylpiperazin-1-YL)-1,2,3,4-tetrahydro-2-naphthyl)-4-morpholinobenzamide
DE60134735D1 (de) Neue neurokinin-antagonisten zum gebrauch als arzneimittel
IL161748A0 (en) New use for the treatment of gastroesophageal reflux
IL155706A0 (en) Process for the preparation of (r)-5-(2-benzenesulfonylethyl)-3-(n-methylpyrrolidin-2-ylmethyl)-1h-indole
PT1698338E (pt) S-metil-di-hidro-ziprasidona para o tratamento de distúrbios psiquiátricos
NZ516209A (en) Indoloazepines as vasopressin receptor antagonists
HU0000307D0 (en) Neuropeptide y antagonists
ZA200205835B (en) Compounds useful for the treatment or prevention of a disease mediated by the alpha-2B-adrenoceptor.
IL135993A0 (en) Pharmaceutical composition for the treatment of fibrosis
HRP20020746A2 (en) Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor
HU0003973D0 (en) Pharmaceutical composition for the treatment of aids
RU2000122595A (ru) Лекарственное средство для лечения пиелонефрита
ZA997090B (en) "A composition for the treatment of wood".